Stinchcomb Clinton Larry bought CURI

Footnotes

On July 15, 2025, the Company granted Mr. Stinchcomb 2,400,000 restricted stock units (RSUs) with tandem dividend equivalent rights under the 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of common stock. The RSUs granted are performance-based, subject to the Company's achieving certain stock price or financial performance goals. All vesting is subject to continued employment on the applicable vesting date and any RSUs not earned during the term of Mr. Stinchcomb's employment agreement will be cancelled. The dividend equivalents entitle Mr. Stinchcomb to payout of dividends accrued on each unvested RSU to the extent such RSUs vest and are distributed under the Agreement.; The RSUs granted will vest in four equal tranches of 600,000 each upon the date the Board determines that the applicable performance condition has been achieved: (i) the Company common stock achieves a 10 day volume weighted average price (VWAP) of $6.50, or the Company achieves 35% year over year revenue growth for the period January 1 through June 30, 2025, compared to the same period in 2024; (ii) the common stock achieves a 10-day VWAP of $7.50, or the Company achieves 40% revenue growth and 35% adjusted free cash flow growth for the full year 2025 compared to 2024; (iii) the common stock achieves a 10-day VWAP of $9.50; and (iv) the common stock achieves a 10-day VWAP of $11.50.